ValiRx plc (LON:VAL – Get Free Report) shares fell 1.7% during trading on Monday . The company traded as low as GBX 0.16 and last traded at GBX 0.18. Approximately 12,977,390 shares traded hands during trading, an increase of 32% from the average session volume of 9,839,466 shares. The stock had previously closed at GBX 0.18.
ValiRx Stock Down 1.7%
The firm’s 50-day simple moving average is GBX 0.23 and its 200 day simple moving average is GBX 0.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.27 and a current ratio of 9.66. The company has a market cap of £1.28 million, a P/E ratio of -0.18 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.The company had revenue of GBX 3 million during the quarter. On average, research analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
